[1]
Boccadoro, M., Berto, P., Bringhen, S., Zamagni, E., Tosi, P., Cascavilla, N., Giuliani, N., Mannina, D., Zambello, R., Patriarca, F., Montefusco, V., Grasso, M., Di Raimondo, F., Offidani, M., Petrucci, M.T. and Musto, P. 2021. Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus. Global and Regional Health Technology Assessment. 8, 1 (Jul. 2021), 80–86. DOI:https://doi.org/10.33393/grhta.2021.2245.